Figure 4From: Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancerKaplan-Meier survival plot for luminal BC validation set using Ki-67LI and MS. (a) Breast cancer-specific survival (BCSS) and (b) metastasis-free survival at 10% and 50% Ki-67LI cut-off point. (c, d) BCSS and DMFS for mitosis frequency scores (by using the validation set only).Back to article page